NSP-SA-NHS

CAS No. 199293-83-9

NSP-SA-NHS( —— )

Catalog No. M27039 CAS No. 199293-83-9

NSP-SA-NHS is a chemiluminescent acridinium ester that can be used for immunoassays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 215 Get Quote
10MG 340 Get Quote
25MG 565 Get Quote
50MG 797 Get Quote
100MG 1071 Get Quote
200MG 1431 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NSP-SA-NHS
  • Note
    Research use only, not for human use.
  • Brief Description
    NSP-SA-NHS is a chemiluminescent acridinium ester that can be used for immunoassays.
  • Description
    NSP-SA-NHS is a chemiluminescent acridinium ester that can be used for immunoassays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Nucleoside Analogue
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    199293-83-9
  • Formula Weight
    681.73
  • Molecular Formula
    C32H31N3O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 11.36 mg/mL (16.66 mM)
  • SMILES
    Cc1ccc(cc1)S(=O)(=O)N(CCCC(=O)ON1C(=O)CCC1=O)C(=O)c1c2ccccc2[n+](CCCS([O-])(=O)=O)c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kunihiro HIRAI, et al. Base-protected oligonucleotide. EP2816053A1
molnova catalog
related products
  • ASK1-IN-1

    ASK1-IN-1 is an inhibitor of apoptosis signal-regulating kinase 1 which is a key mediator in the apoptotic and inflammatory cellular stress response with an IC50 of 21 nM in biochemica assays.

  • Omalizumab

    Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).

  • Osteogenic Growth Pe...

    Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.